American Journal of Kidney Diseases
Volume 54, Issue 1 , Pages 43-50 , July 2009

Hepatitis C Seropositivity and Kidney Function Decline Among Women With HIV: Data From the Women's Interagency HIV Study

  • Judith Tsui, MD, MPH

      Affiliations

    • Boston University School of Medicine, Boston, MA
    • Corresponding Author InformationAddress correspondence to Judith Tsui, MD, MPH, Boston University School of Medicine, 801 Massachusetts Ave, 2nd floor, Boston, MA 02118
    • ,
  • Eric Vittinghoff, PhD

      Affiliations

    • University of California, San Francisco, CA
    • ,
  • Kathryn Anastos, MD

      Affiliations

    • Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY
    • ,
  • Michael Augenbraun, MD

      Affiliations

    • SUNY Downstate, Brooklyn, NY
    • ,
  • Mary Young, MD

      Affiliations

    • Georgetown University, Washington, DC
    • ,
  • Marek Nowicki, PhD

      Affiliations

    • University of Southern California, Los Angeles, CA
    • ,
  • Mardge H. Cohen, MD

      Affiliations

    • CORE Center, Cook County Bureau of Health Services and Rush University, Chicago, IL
    • ,
  • Marion G. Peters, MD

      Affiliations

    • University of California, San Francisco, CA
    • ,
  • Elizabeth T. Golub, PhD

      Affiliations

    • Johns Hopkins University, Baltimore, MD
    • ,
  • Lynda Szczech, MD, MSCE

      Affiliations

    • Duke University, Raleigh-Durham, NC

Received 27 November 2008 ,Accepted 14 January 2009.

References 

  1. Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH. Hepatitis C and renal disease: An update. Am J Kidney Dis. 2003;42:631–657
  2. Ramos-Casals M, Trejo O, Garcia-Carrasco M, Font J. Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection. Rheumatology (Oxford). 2003;42:818–828
  3. Sulkowski MS, Thomas DL. Hepatitis C in the HIV-infected person. Ann Intern Med. 2003;138:197–207
  4. Sulkowski MS, Benhamou Y. Therapeutic issues in HIV/HCV-coinfected patients. J Viral Hepat. 2007;14:371–386
  5. Szczech LA, Gange SJ, van der Horst C, et al. Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int. 2002;61:195–202
  6. Franceschini N, Napravnik S, Eron JJ, Szczech LA, Finn WF. Incidence and etiology of acute renal failure among ambulatory HIV-infected patients. Kidney Int. 2005;67:1526–1531
  7. Atta MG, Gallant JE, Rahman MH, et al. Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrol Dial Transplant. 2006;21:2809–2813
  8. Gardner LI, Holmberg SD, Williamson JM, et al. Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr. 2003;32:203–209
  9. Bacon MC, von Wyl V, Alden C, et al. The Women's Interagency HIV Study: An observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol. 2005;12:1013–1019
  10. Barkan SE, Melnick SL, Preston-Martin S, et al. The Women's Interagency HIV Study (WIHS Collaborative Study Group). Epidemiology. 1998;9:117–125
  11. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation (Modification of Diet in Renal Disease Study Group). Ann Intern Med. 1999;130:461–470
  12. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;11:155A;(abstr A0828)
  13. Gupta SK, Eustace JA, Winston JA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005;40:1559–1585
  14. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–147
  15. Vittinghoff E, Glidden D, Shiboski S, McCulloch C. Regression Methods in Biostatistics. (ed 1). New York, LLC: Springer-Verlag; 2005;
  16. Gumber SC, Chopra S. Hepatitis C: A multifaceted disease (Review of extrahepatic manifestations). Ann Intern Med. 1995;123:615–620
  17. Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med. 1993;328:465–470
  18. McGuire BM, Julian BA, Bynon JS, et al. Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann Intern Med. 2006;144:735–741
  19. Stehman-Breen C, Willson R, Alpers CE, Gretch D, Johnson RJ. Hepatitis C virus-associated glomerulonephritis. Curr Opin Nephrol Hypertens. 1995;4:287–294
  20. Yamabe H, Johnson RJ, Gretch DR, et al. Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol. 1995;6:220–223
  21. Crook ED, Penumalee S, Gavini B, Filippova K. Hepatitis C is a predictor of poorer renal survival in diabetic patients. Diabetes Care. 2005;28:2187–2191
  22. Freiberg MS, Cheng DM, Kraemer KL, Saitz R, Kuller LH, Samet JH. The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individuals. AIDS. 2007;21:193–197
  23. Fukui M, Kitagawa Y, Nakamura N, Yoshikawa T. Hepatitis C virus and atherosclerosis in patients with type 2 diabetes. JAMA. 2003;289:1245–1246
  24. Ishizaka Y, Ishizaka N, Takahashi E, et al. Association between hepatitis C virus core protein and carotid atherosclerosis. Circ J. 2003;67:26–30
  25. Vassalle C, Masini S, Bianchi F, Zucchelli GC. Evidence for association between hepatitis C virus seropositivity and coronary artery disease. Heart. 2004;90:565–566
  26. Tsui JI, Vittinghoff E, Shlipak MG, et al. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease. Arch Intern Med. 2007;167:1271–1276
  27. Caregaro L, Menon F, Angeli P, et al. Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Arch Intern Med. 1994;154:201–205
  28. Skluzacek PA, Szewc RG, Nolan CR, Riley DJ, Lee S, Pergola PE. Prediction of GFR in liver transplant candidates. Am J Kidney Dis. 2003;42:1169–1176
  29. Bonacini M, Lin HJ, Hollinger FB. Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus. J Acquir Immune Defic Syndr. 2001;26:340–344
  30. Chamie G, Bonacini M, Bangsberg DR, et al. Factors associated with seronegative chronic hepatitis C virus infection in HIV infection. Clin Infect Dis. 2007;44:577–583
  31. Cohen MH, Grey D, Cook JA, et al. Awareness of hepatitis C infection among women with and at risk for HIV. J Gen Intern Med. 2007;22:1689–1694

 Originally published online as doi: 10.1053/j.ajkd.2009.02.009 on April 27, 2009.

PII: S0272-6386(09)00443-0

doi: 10.1053/j.ajkd.2009.02.009

American Journal of Kidney Diseases
Volume 54, Issue 1 , Pages 43-50 , July 2009

Article Tools

* Image Usage & Resolution